Pituitary Diseases clinical trials

The registry lists 74 studies for Pituitary Diseases across more than 10 countries. 15 are recruiting or about to start. 18 of them are mainly about Pituitary Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-26. Counting its 11 narrower conditions too, such as Dwarfism, Pituitary: 1,015 studies, 166 open.

Get an email when these change. Save the Pituitary Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 39
Recruiting: 12
Status unknown: 11
Terminated: 7
Not yet recruiting: 3
Approved for marketing: 1

Phase

Phase 3: 16
Phase 2: 7
Phase 4: 4
Phase 1: 1

Where

United States: 34
Italy: 10
France: 9
Germany: 5
Spain: 5
Poland: 5

Who runs them

Corcept Therapeutics (4) · Hospices Civils de Lyon (3) · Novartis Pharmaceuticals (3) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2) · Washington University School of Medicine (2) · Massachusetts General Hospital (2) · Cedars-Sinai Medical Center (2) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (2)

What is being tested here

Drugs under test in Pituitary Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Osilodrostat	1	1	3
Human Growth Hormone	0	1	3
Mifepristone	0	3	3
Pegvisomant	0	1	2
Ipilimumab	0	0	1
Nivolumab	0	0	1
LY2940680	0	0	1
Exenatide	0	0	1
Clomiphene	0	0	1
Acipimox	0	0	1

Coming up

2phase 3 studies under way

3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Dec 2026Long Term Outcome Study in Patients With Pituitary Disorders · University of Alberta
Jul 2027Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome · RECORDATI GROUP
Nov 2027Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitary Neuroendocrine Tumors. · Hospices Civils de Lyon

Who these studies take

Of the 12 Pituitary Diseases studies recruiting now, 6 (50%) set no upper age limit and 3 (25%) stop at 75 or younger. 3 (25%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 12
Age	Women	Men
10	2 (17%)	2 (17%)
18	11 (92%)	11 (92%)
30	11 (92%)	11 (92%)
40	11 (92%)	11 (92%)
50	11 (92%)	11 (92%)
65	11 (92%)	11 (92%)
75	10 (83%)	10 (83%)
85	9 (75%)	9 (75%)

Across all 74 studies, recruiting or not: 35% stop at 75 or younger and 20% at 65; 27% take children; 1% are for women only and 4% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Radiosurgery for Severe Refractory Cancer Pain: A Sham-Controlled Pilot TrialOct 13, 2026NCT07871123

Studies

Recruiting first, then most recently updated. Showing 50 of 74. Browse all 74 → or search them.